Articles published by Orano Med

Orano Med Provides Half-Year Progress Report and Business Outlook

July 31, 2026

From Orano Med

Via Business Wire

Three New Independent Members Join Orano Med’s Governing Board

July 09, 2026

From Orano Med

Via Business Wire

The European Investment Bank Grants Orano a Loan of €125 Million to Finance Orano Med’s Innovations and Industrial Infrastructure

July 01, 2026

From Orano Med

Via Business Wire

Orano Announces the Appointment of Frederic Desdouits as CEO of Orano Med

April 08, 2026

From Orano Med

Via Business Wire

Orano Med Enters Next Phase of Collaboration With Roche

December 04, 2025

From Orano Med

Via Business Wire

Orano Med Achieves Key Milestone in French ATEF Facility Construction, an Essential Asset for Large-Scale Production of Innovative Lead-212-based Therapies

September 12, 2025

From Orano Med

Via Business Wire

Orano Med Inaugurates Expansion of its U.S. Research and Development Center in Texas

June 26, 2025

From Orano Med

Via Business Wire

RadioMedix and Orano Med receive FDA Breakthrough Therapy Designation for AlphaMedixTM in gastroenteropancreatic neuroendocrine tumors

February 12, 2024

From Orano Med

Via Business Wire

RadioMedix and Orano Med Complete Patient Enrolment in Phase II Trial of Targeted Alpha-Emitter AlphaMedix in Neuroendocrine Cancers

May 16, 2023

From Orano Med

Via Business Wire

Orano Med Starts Phase I Trial With Alpha Radioligand Therapy 212Pb-GRPR in Patients With Solid Tumors

January 04, 2023

From Orano Med

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.